| known also as: |
Anti-RABBIT ANTI HUMAN BARD1 |
| known also as: |
RABBIT ANTI HUMAN BARD1 |
| known also as: |
Lapin ANTI Homo sapiens BARD1 |
| known also as: |
BARD1 |
| Other names: |
BARD-1, BRCA1 associated RING domain 1, BRCA1 associated RING domain 1 isoform alfa, BRCA1 associated RING domain 1 isoform beta, BRCA1 associated RING domain 1 isoform delta, BRCA1 associated RING domain 1 isoform epsilon, BRCA1 associated RING domain 1 isoform eta, BRCA1 associated RING domain 1 isoform gamma, BRCA1 associated RING domain 1 isoform phi, BRCA1-associated RING domain gene 1, BRCA1-associated RING domain protein 1, BRCA1-associated RING domain protein 1, N/A, BRCA1-associated RING domain protein 1 |
| Gene name: |
BARD1 |
| Other gene names: |
BARD-1, BARD1, N/A, BARD1 |
| Category: |
Antibodies |
| Clonality: |
Polyclonal |
| Immunoglobulin isotype: |
Polyclonal IgG |
| Clone: |
Polyclonal antibody |
| Host organism: |
Rabbit |
| Species reactivity: |
Human |
| Specificity and cross-reactivity: |
As the name suggests, BARD1 is thought to play a key role in regulating BRCA1 stability, _x000D__x000D_BARD1 is also reported to function as a tumour suppressor, _x000D__x000D_BARD1 possesses an N-terminal RING motif and the C-terminal BRCT domain, localisation and function, since mutations in this protein have been implicated in a number of breast and ovarian cancers, this protein is the major cellular binding protein of BRCA1, BARD1 This item is specific for human BARD1 (BRCA1 associated Ring Domain 1) |
| Form/Appearance: |
Purified (Purified IgG - liquid) |
| Concentration: |
0 mg/ml, IgG concentration 1 |
| Storage and shipping: |
Avoid repeated freezing and thawing as this may denature the antibody, Shelf Life: 18 months from date of dispatch, Should productone contain a precipitate we recommend microcentrifugation before use, Storage in frost free freezers is not recommended, if preferred, or productone should be stored at -20 degrees Celsius, productone should be stored undiluted, Store at +Store productone at +4 degrees Celsius |
| Tested for:: |
Western Blot (WB), Immunoprecipitation (IP) |
| Description: |
Polyclonal antibodies generally are more stable and retain their reactivity under unfavorable conditions, Polyclonal antibodies have series of advantages - larger batches can be supplied at a time, Properly used, To obtain more detailed information on productone, please, refer to the full product datasheet, the time needed for production is considerably shorter, they are inexpensive to manufacture and respectively to buy, this antibody will ensure excellent and reproducible results with guaranteed success for the applications that it is tested in, productone is a polyclonal antibody of high purity and binding affinity for the antigen that it is risen against |
| Advisory: |
For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, avoid cycles of freezing and thawing, please, In order to retain the quality and the affinity of productone unchanged |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals_1 they should be stored frozen at - 24° |
| Gene target: |
BARD1 |
| Short name: |
Anti-HUMAN BARD1 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
early onset associated RING domain 1 (Antibody to), sapiens breast cancer 1, antibody to-H |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
BARD1 and IDBG-643630 and ENSBTAG00000033690 and 530961, BARD1 and IDBG-80113 and ENSG00000138376 and 580, Bard1 and IDBG-164443 and ENSMUSG00000026196 and 12021, nuclei, protein heterodimerization activity, this GO :0000151 and ubiquitin ligase complex and cellular component this GO :0001894 and tissue homeostasis and biological process this GO :0003723 and RNA binding and molecular function this GO :0004842 and ubiquitin-protein transferase activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005730 and nucleolus and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0006281 and DNA repair and biological process this GO :0006974 and cellular response to DNA damage stimulus and biological process this GO :0007050 and cell cycle arrest and biological process this GO :0008270 and zinc ion binding and molecular function this GO :0016567 and protein ubiquitination and biological process this GO :0016874 and ligase activity and molecular function this GO :0019900 and kinase binding and molecular function this GO :0031436 and BRCA1-BARD1 complex and cellular component this GO :0031441 and negative regulation of mRNA 3'-end processing and biological process this GO :0042325 and regulation of phosphorylation and biological process this GO :0042803 and protein homodimerization activity and molecular function this GO :0043065 and positive regulation of apoptotic process and biological process this GO :0043066 and negative regulation of apoptotic process and biological process this GO :0043231 and intracellular membrane-bounded organelle and cellular component this GO :0045732 and positive regulation of protein catabolic process and biological process this GO :0046826 and negative regulation of protein export from nucleus and biological process this GO :0046982 and protein heterodimerization activity and molecular function this GO :0070531 and BRCA1-A complex and cellular component this GO :0085020 and protein K6-linked ubiquitination and biological process, this GO :0003723 : RNA binding, this GO :0003723 : RNA binding and also this GO :0004842 : ubiquitin-protein transferase activity and also this GO :0005515 : protein binding and also this GO :0008270 : zinc ion binding and also this GO :0016874 : ligase activity and also this GO :0019900 : kinase binding and also this GO :0042803 : protein homodimerization activity and also this GO :0046982 : protein heterodimerization activity, this GO :0004842 : ubiquitin-protein transferase activity, this GO :0005515 : protein binding, this GO :0008270 : zinc ion binding, this GO :0016874 : ligase activity, this GO :0019900 : kinase binding, this GO :0042803 : protein homodimerization activity, this GO :0046982 : protein heterodimerization activity, BRCA1 associated RING domain 1 |
| Identity: |
952 |
| Gene: |
BARD1 |
More about : BARD1 |
| Long gene name: |
BRCA1 associated RING domain 1 |
| Locus: |
2q35 |
| Discovery year: |
1998-08-05 |
| Entrez gene record: |
580 |
| Pubmed identfication: |
8944023 9425226 15159397 |
| RefSeq identity: |
NM_000465 |
| Classification: |
Ankyrin repeat domain containing BRCA1 B complex |
| Havana BLAST/BLAT: |
OTTHUMG00000133016 |